ACTRN12612001011875Recruiting未知
Ten Year Survivorship and Clinical Outcome of the Genesis II Prosthesis for Total Knee Replacement
Associate Professor Leo Pinczewski0 sites340 target enrollmentStarted: September 19, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 340
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- o limit to o limit (—)
- Sex
- All
Inclusion Criteria
- •1.Primary Total knee replacement
- •2.Genesis II prosthesis
- •3.Patients willing to participate in a research program
- •4.No rheumatoid arthritis
- •5.Preop Fixed flexion deformity of < 15 degrees
Exclusion Criteria
- •1. Patients seeking compensation for their knee condition
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Ten-Year Observational Study of Clinical Characteristics and Treatment Outcomes of Thai Patients with Hodgkin Lymphoma: A Dual-Center ExperienceDiagnosis of newly diagnosed Hodgkin lymphoma patients aged grater than 18 years at Siriraj Hospital and Vichira Phuket Hospital between 1 January 2013 and 31 December 2022.Ten-Year Observational Study of Clinical Characteristics , Treatment Outcomes of Thai Patients with Hodgkin Lymphoma, A Dual-Center Experience.TCTR20240529010Siriraj Hospital Mahidol University230
Not yet recruiting
Not Applicable
Study on survival from prolonged cardiac arrest treated with an artificial blood pump (ECMO)Cardiovascular - Other cardiovascular diseasesrefractory cardiac arrestACTRN12615000779572A/Prof Paul Forrest25
Completed
Not Applicable
Clinical observation study of 5-year survivals in patients with newly diagnosed acute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML) in Japan Adult Leukemia Study GroupAcute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML)JPRN-UMIN000008371Japan Adult Leukemia Study Group6,100
Completed
Not Applicable
Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12)Acute lymphoblastic leukemiaJPRN-UMIN000007653Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group733
Recruiting
Not Applicable
Clinical and radiological results 10 years after a deepening trochleoplastyTrochleoplastyTrochlear dysplasia10005944NL-OMON50571Sint Maartenskliniek36